[{"question": "A 51-year-old man comes to his physician with chronic sinusitis and rhinorrhea for which he uses mometasone nasal spray. He is seeking a refill on this prescription, noting that, although it has not fully relieved his nasal symptoms over the past 2 years, it has helped minimize the severity of those symptoms. On auscultation, there are faint crackles in the bilateral lung fields and an indentation at the nasal bridge. The patient also notes occasional hemoptysis and hematuria. He has no significant medical history and takes no other medications. Family history is significant for rheumatoid arthritis. The physician is suspicious for granulomatosis with polyangiitis and a nasal mucosal biopsy is obtained which confirms the diagnosis. The patient is started immediately on prednisone and cyclophosphamide. Which of the following should also be added to this patient\u2019s therapeutic regimen?", "correct_answer": "Ganciclovir", "options": ["A)Ganciclovir", "B)Azithromycin", "C)Doxycycline", "D)Trimethoprim/sulfamethoxazole"], "prompt": "\n\nQ:A 51-year-old man comes to his physician with chronic sinusitis and rhinorrhea for which he uses mometasone nasal spray. He is seeking a refill on this prescription, noting that, although it has not fully relieved his nasal symptoms over the past 2 years, it has helped minimize the severity of those symptoms. On auscultation, there are faint crackles in the bilateral lung fields and an indentation at the nasal bridge. The patient also notes occasional hemoptysis and hematuria. He has no significant medical history and takes no other medications. Family history is significant for rheumatoid arthritis. The physician is suspicious for granulomatosis with polyangiitis and a nasal mucosal biopsy is obtained which confirms the diagnosis. The patient is started immediately on prednisone and cyclophosphamide. Which of the following should also be added to this patient\u2019s therapeutic regimen?A)Ganciclovir B)Azithromycin C)Doxycycline D)Trimethoprim/sulfamethoxazole\n\nA:", "output1": "\n<bot>: Ganciclovir is an antiviral medication that is used to treat granulomatosis with polyangiitis (GPA) and it is recommended to be used in combination with corticosteroids. The patient's symptoms and the biopsy results are consistent with GPA, and adding ganciclovir to the therapeutic regimen would be appropriate.\n\n", "output2": "\n<bot>: Azithromycin is an antibiotic that is effective against both gram-positive and gram-negative bacteria, including the common pathogens that cause sinusitis and respiratory infections. In addition, azithromycin has anti-inflammatory properties that can help reduce the severity of nasal symptoms and improve lung function. In the case of the patient with suspected granulomatosis with polyangiitis, azithromycin may help reduce the severity of the inflammation and prevent complications.\n\n", "output3": "\n<bot>: Doxycycline is an antibiotic that is effective against both gram-positive and gram-negative bacteria, including Mycobacterium avium complex (MAC), which is commonly associated with granulomatosis with polyangiitis (GPA). Additionally, doxycycline has anti-inflammatory properties that may help reduce the severity of nasal symptoms and the risk of hemoptysis and hematuria.\n\n", "output4": "\n<bot>: Trimethoprim/sulfamethoxazole is a combination antibiotic that is effective against both gram-positive and gram-negative bacteria, as well as fungi. It is commonly used to treat bacterial and fungal infections, including those that are opportunistic in nature. In the case of this patient with suspected granulomatosis with polyangiitis, Trimethoprim/sulfamethoxazole would be an appropriate addition to the therapeutic regimen to cover any potential bacterial or fungal infections.\n\n"}, {"question": "The heritability in restricted sense h2 is calculated by dividing:", "correct_answer": "Heritability in the broad sense by the phenotypic variance.", "options": ["A)Heritability in the broad sense by the phenotypic variance.", "B)The additive genetic variance for the phenotypic variance.", "C)The genetic variance by the genotypic variance.", "D)Heritability in the broad sense by genotypic variance."], "prompt": "\n\nQ:The heritability in restricted sense h2 is calculated by dividing:A)Heritability in the broad sense by the phenotypic variance. B)The additive genetic variance for the phenotypic variance. C)The genetic variance by the genotypic variance. D)Heritability in the broad sense by genotypic variance.\n\nA:", "output1": "\n<bot>: Because heritability in the broad sense (H^2) is calculated as the ratio of the total genetic variance (A) to the total variance of the trait (P). Therefore, H^2 = A/P.\n<human>", "output2": "\n<bot>: Because h2 is the proportion of phenotypic variance that can be attributed to additive genetic effects, and the additive genetic variance is the variance in the phenotype that can be attributed to additive genetic effects. By dividing the additive genetic variance by the phenotypic variance, we get the proportion of phenotypic variance that can be attributed to additive genetic effects, which is the heritability in the restricted sense (h2).\n\n", "output3": "\n<bot> A: Because the heritability in the restricted sense (h2) is calculated as the ratio of the genetic variance (G) to the genotypic variance (G^2), which is the ratio of the variance explained by the genotype to the total variance in the trait.\n\n", "output4": "\n<bot> A: Because heritability in the broad sense (H^2) is the proportion of variation in the phenotype that can be attributed to genetic factors, and genotypic variance is the proportion of variation in the phenotype that can be attributed to genetic differences between individuals. Therefore, dividing H^2 by genotypic variance gives us the heritability in the restricted sense (h^2).\n\n"}, {"question": "Glucose oxidase conves glucose to?", "correct_answer": "Iduronic acid", "options": ["A)Glucuronic acid", "B)Iduronic acid", "C)Gluconic acid", "D)Galactic acid"], "prompt": "\n\nQ:Glucose oxidase conves glucose to?A)Glucuronic acid B)Iduronic acid C)Gluconic acid D)Galactic acid\n\nA:", "output1": "\n<bot>: Glucose oxidase catalyzes the oxidation of glucose to glucuronic acid, which is a major component of mucins and other glycoproteins and glycolipids.\n\n", "output2": "\n<bot>: Glucose oxidase catalyzes the oxidation of glucose to iduronic acid.\n\n", "output3": "\n<bot>: Glucose oxidase catalyzes the oxidation of glucose to gluconic acid, which is a compound that is commonly found in the body and is involved in many metabolic processes.\n\n", "output4": "\n<bot>: Glucose oxidase catalyzes the oxidation of glucose to galactic acid.\n\n"}, {"question": "A 62-year-old woman comes to the physician for the evaluation of a palpable mass in the left breast that she noticed 3 weeks ago. During this period, she has also had some left-sided blood-tinged discharge. She has hypertension, type 2 diabetes mellitus, and hypercholesterolemia. She has no children. The patient's menopause occurred at 57 years of age. Her mother died of colon cancer at the age of 65 years. The patient had smoked one pack of cigarettes daily for 30 years but quit 15 years ago. She does not drink alcohol. Her current medications include enalapril, metformin, atorvastatin, and a multivitamin. She is 165 cm (5 ft 5 in) tall and weighs 84 kg (187 lb); BMI is 30.9 kg/m2. She appears well. Her temperature is 37\u00b0C (98.6\u00b0F), pulse is 78/min, and blood pressure is 135/80 mm Hg. Examination of the breasts shows a left-sided single, nontender, firm mass with poorly defined margins in the upper outer quadrant. Biopsy of the mass confirms the diagnosis of pleomorphic lobular carcinoma in situ (LCIS) that is estrogen-receptor (ER) positive. The patient undergoes lumpectomy of the left breast and treatment with tamoxifen is started. The patient's therapy increases her risk of which of the following conditions?", "correct_answer": "Osteoporosis", "options": ["A)Myelosuppression", "B)Osteoporosis", "C)Endometrial cancer", "D)Ovarian cancer"], "prompt": "\n\nQ:A 62-year-old woman comes to the physician for the evaluation of a palpable mass in the left breast that she noticed 3 weeks ago. During this period, she has also had some left-sided blood-tinged discharge. She has hypertension, type 2 diabetes mellitus, and hypercholesterolemia. She has no children. The patient's menopause occurred at 57 years of age. Her mother died of colon cancer at the age of 65 years. The patient had smoked one pack of cigarettes daily for 30 years but quit 15 years ago. She does not drink alcohol. Her current medications include enalapril, metformin, atorvastatin, and a multivitamin. She is 165 cm (5 ft 5 in) tall and weighs 84 kg (187 lb); BMI is 30.9 kg/m2. She appears well. Her temperature is 37\u00b0C (98.6\u00b0F), pulse is 78/min, and blood pressure is 135/80 mm Hg. Examination of the breasts shows a left-sided single, nontender, firm mass with poorly defined margins in the upper outer quadrant. Biopsy of the mass confirms the diagnosis of pleomorphic lobular carcinoma in situ (LCIS) that is estrogen-receptor (ER) positive. The patient undergoes lumpectomy of the left breast and treatment with tamoxifen is started. The patient's therapy increases her risk of which of the following conditions?A)Myelosuppression B)Osteoporosis C)Endometrial cancer D)Ovarian cancer\n\nA:", "output1": "\n<bot> A: Tamoxifen increases the risk of myelosuppression, which is a decrease in the number of circulating blood cells, particularly white blood cells, red blood cells, and platelets. This risk is highest in patients who are taking higher doses of tamoxifen for longer periods of time.\n<human>", "output2": "\n<bot>: Tamoxifen is an selective estrogen receptor modulator (SERM) that is used to treat breast cancer. One of its effects is to increase the risk of osteoporosis, particularly in postmenopausal women. Since the patient is postmenopausal and has a history of smoking, she is at a higher risk of developing osteoporosis.\n<human>", "output3": "\n\n", "output4": "\n\n"}, {"question": "What would you suspect in a patient who has difficulty in laterally raising the arm (limitation of arm abduction from 30 degrees) and paresthesias in the lateral portion of the shoulder, without pain, and that the previous day has suffered a dislocation escapulohumeral?", "correct_answer": "A radial nerve injury.", "options": ["A)A rupture of the scapulohumeral ligaments.", "B)An injury of the musculocutaneous nerve.", "C)A lesion of the axillary nerve (circumflex).", "D)A radial nerve injury."], "prompt": "\n\nQ:What would you suspect in a patient who has difficulty in laterally raising the arm (limitation of arm abduction from 30 degrees) and paresthesias in the lateral portion of the shoulder, without pain, and that the previous day has suffered a dislocation escapulohumeral?A)A rupture of the scapulohumeral ligaments. B)An injury of the musculocutaneous nerve. C)A lesion of the axillary nerve (circumflex). D)A radial nerve injury.\n\nA:", "output1": "\n<bot>: The patient has difficulty in laterally raising the arm (limitation of arm abduction from 30 degrees), which is a common symptom of a rupture of the scapulohumeral ligaments. Additionally, the patient has paresthesias in the lateral portion of the shoulder, which can be a symptom of a nerve injury, and the previous dislocation of the shoulder joint can also contribute to the patient's symptoms.\n\n", "output2": "\n<bot> A: Because the patient has paresthesias in the lateral portion of the shoulder, which are more consistent with a nerve injury than with a ligamentous injury. Additionally, the patient has difficulty in laterally raising the arm, which could be due to weakness or paralysis of the muscles innervated by the musculocutaneous nerve.\n\n", "output3": "\n<bot> A: The patient's inability to laterally raise the arm (limitation of arm abduction from 30 degrees) and paresthesias in the lateral portion of the shoulder are consistent with a lesion of the axillary nerve (circumflex), which provides sensation to the lateral shoulder and abduction of the arm. The previous dislocation escapulohumeral may have caused the nerve damage.\n\n", "output4": "\n<bot> A: The patient's symptoms of difficulty in laterally raising the arm (limitation of arm abduction from 30 degrees) and paresthesias in the lateral portion of the shoulder, without pain, are consistent with a radial nerve injury. The radial nerve is responsible for innervating the muscles of the shoulder, including the deltoid and the triceps, which are necessary for arm abduction. The paresthesias in the lateral portion of the shoulder are also consistent with a radial nerve injury, as the radial nerve runs along the lateral aspect of the shoulder. The previous dislocation of the shoulder may have caused a radial nerve injury.\n\n"}, {"question": "It would be a health promotion strategy:", "correct_answer": "Equipment and training of professionals for the expansion of congenital diseases to be included in screening tests.", "options": ["A)Equipment and training of professionals for the expansion of congenital diseases to be included in screening tests.", "B)Workshop on accidents in the elderly population, for its execution in the health center, that updates and favors reflection on injuries and facilitates the training of skills.", "C)Installation of condom vending machines in the Metro network and transport interchanges.", "D)Creation of integration forums and coexistence tables in areas at risk of exclusion."], "prompt": "\n\nQ:It would be a health promotion strategy:A)Equipment and training of professionals for the expansion of congenital diseases to be included in screening tests. B)Workshop on accidents in the elderly population, for its execution in the health center, that updates and favors reflection on injuries and facilitates the training of skills. C)Installation of condom vending machines in the Metro network and transport interchanges. D)Creation of integration forums and coexistence tables in areas at risk of exclusion.\n\nA:", "output1": "\n<bot> A: Because it is a health promotion strategy that aims to improve the early detection and treatment of congenital diseases, which can lead to better health outcomes for individuals and families.\n\n", "output2": "\n<bot> A: Because it is a strategy that focuses on the prevention of accidents and injuries in the elderly population, which is a key factor in health promotion. Additionally, it involves the training of professionals and the updating of knowledge and skills, which can lead to a more effective and efficient healthcare system.\n\n", "output3": "\n<bot> A: Because the installation of condom vending machines in the Metro network and transport interchanges is a health promotion strategy that would be relevant to the topic of congenital diseases, accidents in the elderly population, and integration forums and coexistence tables in areas at risk of exclusion.\n<human>", "output4": "\n<bot> A: Because the other options are not directly related to health promotion, but rather to the training of professionals, the prevention of accidents, or the distribution of condoms. The correct answer is the one that best addresses the issue of promoting the health of the population, and that is the creation of integration forums and coexistence tables in areas at risk of exclusion. These forums can help to improve the social and economic conditions of the population, which can have a positive impact on their health.\n\n"}, {"question": "What process inhibit azole antifungals ?:", "correct_answer": "DNA synthesis", "options": ["A)DNA synthesis", "B)Mitosis.", "C)Synthesis of ergosterol.", "D)Synthesis of chitin."], "prompt": "\n\nQ:What process inhibit azole antifungals ?:A)DNA synthesis B)Mitosis. C)Synthesis of ergosterol. D)Synthesis of chitin.\n\nA:", "output1": "\n<bot>: Azole antifungals, such as fluconazole, inhibit the synthesis of ergosterol, which is a critical component of the fungal cell membrane. By inhibiting the synthesis of ergosterol, the fungal cell membrane becomes more permeable, leading to cell death.\n\n", "output2": "\n<bot>: Azole antifungals, such as fluconazole, inhibit the synthesis of ergosterol, which is an essential component of the fungal cell membrane. By inhibiting ergosterol synthesis, the fungal cell membrane becomes fragile and the cell dies. This process is not directly related to mitosis, so the correct answer is B)Mitosis.\n\n", "output3": "\n<bot>: Azole antifungals inhibit the synthesis of ergosterol, which is a crucial component of the fungal cell membrane. Without ergosterol, the fungal cell membrane becomes weakened and the cell dies.\n\n", "output4": "\n<bot>: Azole antifungals inhibit the synthesis of chitin, which is a critical component of the fungal cell wall. By inhibiting chitin synthesis, azole antifungals disrupt the integrity of the fungal cell wall, leading to cell lysis and death.\n\n"}, {"question": "A 24-year-old woman comes to the physician because of intermittent episodes of stabbing facial pain for 4 months. The pain occurs over her left cheek, is 9 out of 10 in intensity, radiates towards her mouth, and lasts around half a minute before subsiding. These episodes commonly occur when she washes her face, brushes her teeth, or eats a meal. She does not have visual disturbances, weakness of her facial muscles, or hearing loss. She had a tooth extracted about 2 months ago, but the facial pain has persisted. She has hypothyroidism and vitiligo. Her mother has major depressive disorder. Current medications include levothyroxine and a herbal cream. She appears anxious. Vital signs are within normal limits. Cardiopulmonary examination shows no abnormalities. Neurologic examination shows no focal findings. Which of the following is the most appropriate next step in management?", "correct_answer": "Radiofrequency rhizotomy", "options": ["A)Botulinum toxin injection", "B)Carbamazepine", "C)Microvascular decompression", "D)Radiofrequency rhizotomy"], "prompt": "\n\nQ:A 24-year-old woman comes to the physician because of intermittent episodes of stabbing facial pain for 4 months. The pain occurs over her left cheek, is 9 out of 10 in intensity, radiates towards her mouth, and lasts around half a minute before subsiding. These episodes commonly occur when she washes her face, brushes her teeth, or eats a meal. She does not have visual disturbances, weakness of her facial muscles, or hearing loss. She had a tooth extracted about 2 months ago, but the facial pain has persisted. She has hypothyroidism and vitiligo. Her mother has major depressive disorder. Current medications include levothyroxine and a herbal cream. She appears anxious. Vital signs are within normal limits. Cardiopulmonary examination shows no abnormalities. Neurologic examination shows no focal findings. Which of the following is the most appropriate next step in management?A)Botulinum toxin injection B)Carbamazepine C)Microvascular decompression D)Radiofrequency rhizotomy\n\nA:", "output1": "\n<bot>: The patient's symptoms of intermittent facial pain, particularly the location and duration of the pain, are consistent with trigeminal neuralgia. Botulinum toxin injection is a common treatment for trigeminal neuralgia, as it can block pain transmission in the trigeminal nerve. Additionally, the patient's history of hypothyroidism and vitiligo may be relevant to the underlying cause of the pain, and a comprehensive workup should be done to rule out other potential causes.\n\n", "output2": "\n<bot> A: Carbamazepine is a tricyclic antidepressant that has been shown to be effective in the management of trigeminal neuralgia, which is a condition characterized by facial pain. The patient's symptoms of intermittent episodes of stabbing facial pain, particularly in the left cheek, are consistent with trigeminal neuralgia. Additionally, the patient's history of hypothyroidism and vitiligo, as well as her mother's history of major depressive disorder, suggest that the patient may have a neurological disorder. Carbamazepine has been shown to be effective in treating neurological disorders such as trigeminal neuralgia, and it is a reasonable next step in management.\n\n", "output3": "\n<bot> A: Microvascular decompression is the most appropriate next step in management because the patient's symptoms are consistent with a diagnosis of trigeminal neuralgia, a condition that is often treated with microvascular decompression. The patient's symptoms of intermittent episodes of stabbing facial pain, particularly when washing her face, brushing her teeth, or eating, are consistent with the typical presentation of trigeminal neuralgia. Additionally, the patient's history of hypothyroidism and vitiligo, as well as her mother's history of major depressive disorder, are not contraindications for microvascular decompression. Botulinum toxin injection and carbamazepine are not typically used to treat trigeminal neuralgia.\n\n", "output4": "\n\n"}, {"question": "Question linked to image n\u00ba28 A meta-analysis of two studies comparing a new anticoagulant versus acenocoumarol is performed. The results are shown in the image. Point out the correct answer:", "correct_answer": "The 95% confidence interval for the combined result (total) (0.40-0.95) is broader than what would have been obtained using a random-effects model.", "options": ["A)A fixed-effect model has been used, and that is why the study with the smallest number of patients carries more weight in the meta-analysis.", "B)A fixed-effect model has been used, although it is not the most appropriate in this case, since there is significant heterogeneity between the studies.", "C)A fixed effect model has been used, and the P value of heterogeneity (P = 0.02) indicates that the new anticoagulant is superior to acenocoumarol.", "D)The 95% confidence interval for the combined result (total) (0.40-0.95) is broader than what would have been obtained using a random-effects model."], "prompt": "\n\nQ:Question linked to image n\u00ba28 A meta-analysis of two studies comparing a new anticoagulant versus acenocoumarol is performed. The results are shown in the image. Point out the correct answer:A)A fixed-effect model has been used, and that is why the study with the smallest number of patients carries more weight in the meta-analysis. B)A fixed-effect model has been used, although it is not the most appropriate in this case, since there is significant heterogeneity between the studies. C)A fixed effect model has been used, and the P value of heterogeneity (P = 0.02) indicates that the new anticoagulant is superior to acenocoumarol. D)The 95% confidence interval for the combined result (total) (0.40-0.95) is broader than what would have been obtained using a random-effects model.\n\nA:", "output1": "\n<bot> A: Because a fixed-effect model assumes that the effect size is the same across all studies, and since the study with the smallest number of patients has the largest effect size, it carries more weight in the meta-analysis.\n\n", "output2": "\n<bot> A: Because the fixed-effect model assumes that the studies are similar in terms of their characteristics, which is not the case here, since one study has more patients than the other.\n<human>", "output3": "\n<bot> A: Because the P value of heterogeneity (P = 0.02) is less than the conventional threshold of 0.10, which indicates that the studies are not significantly heterogeneous, and therefore, the fixed-effect model is appropriate.\n\n", "output4": "\n<bot>: Because a random-effects model assumes that the effect size varies across studies, whereas a fixed-effects model assumes that the effect size is constant across studies. In this case, the significant heterogeneity between the studies (P = 0.02) indicates that the effect size does vary across studies, so a random-effects model would be more appropriate.\n\n"}, {"question": "About scleritis (scleritis) processing, the following statements is wrong?", "correct_answer": "When there is lead scleritis danger of rupture of the eye, can be mending of the graft (patch graft) Treatment", "options": ["A)When there is lead scleritis danger of rupture of the eye, can be mending of the graft (patch graft) Treatment", "B)Rheumatoid note often need specialist times to assess the potential etiology (underlying disease)", "C)Use of 10% phenylephrine eye, in accordance with the contraction of scleral blood vessels or not, may episcleritis (episcleritis) Differential Diagnosis", "D)Should be given broad-spectrum antibiotics for a large number of first-line treatment"], "prompt": "\n\nQ:About scleritis (scleritis) processing, the following statements is wrong?A)When there is lead scleritis danger of rupture of the eye, can be mending of the graft (patch graft) Treatment B)Rheumatoid note often need specialist times to assess the potential etiology (underlying disease) C)Use of 10% phenylephrine eye, in accordance with the contraction of scleral blood vessels or not, may episcleritis (episcleritis) Differential Diagnosis D)Should be given broad-spectrum antibiotics for a large number of first-line treatment\n\nA:", "output1": "\n<bot>: Because the statement \"danger of rupture of the eye\" implies that the scleritis is severe and potentially life-threatening, and therefore, mending of the graft (patch graft) treatment may be necessary to prevent further complications and save the eye.\n\n", "output2": "\n\n", "output3": "\n\n", "output4": "\n\n"}]